WARREN, N.J. — GSK Consumer Healthcare Wednesday announced an innovation for Pronamel with the launch of new Pronamel Intensive Enamel Repair toothpaste, designed to help actively repair acid-weakened enamel and protect teeth from future effects of acid erosion with twice daily brushing. Everyday acids in your diet, like green juice, wine and salad dressing, can weaken tooth enamel
WARREN, N.J. — GSK Consumer Healthcare announced a new innovation for Theraflu cold and flu symptom relief with the U.S. launch of Theraflu PowerPods Severe Cold. The brand recognizes consumer’s ever-changing lifestyles and, through this expansion of the current Theraflu portfolio, is modernizing how consumers can achieve cold & flu symptom relief. Compatible with single-serve coffee
WARREN, N.J. – GSK Consumer Healthcare has appointed Amardeep Kahlon as its chief marketing officer and vice president of U.S. marketing. In his new role, Amardeep is responsible for all aspects of marketing in the largest Consumer Healthcare market in the world. Amardeep will report to Colin Mackenzie, region head of the Americas, and become
WARREN, N.J. — GSK Consumer Healthcare has launched Sensodyne Rapid Relief, a new toothpaste formulated for fast relief of tooth pain from sensitivity. GSK said Tuesday that Sensodyne Rapid Relief is clinically proven to alleviate tooth sensitivity in as soon as three days with twice-daily brushing. The toothpaste does this by quickly creating a protective barrier over
CHICAGO — GSK Consumer Healthcare and CVS Health have partnered with American Lung Association’s Lung Force initiative to help people quit smoking. The American Lung Association said that GSK Consumer Healthcare will donate $1 to Lung Force for every box of Nicorette or NicoDerm CQ purchased at CVS Pharmacy through Dec. 2, up to $100,000.
Day two of the NACDS Annual Meeting featured the conference’s first Business Program, led by outgoing chairman Martin Otto of H-E-B and NACDS president and CEO Steve Anderson. Otto and Anderson discussed the think-tank approach to strategy that NACDS is embracing with its Future Value Targeting effort. “The Future Value Targeting initiative that Martin touched
SCOTTSDALE, Ariz. — As part of its “constant reinvention,” the National Association of Chain Drug Stores announced its “Future Value Targeting” initiative at the 2017 NACDS Annual Meeting. During Sunday’s Business Program at the conference, the association’s leadership described the NACDS Future Value Targeting effort as a linchpin of new strategies to drive collaboration that
OAKVILLE, Ontario — The Weather Network and French counterpart MétéoMédia have introduced the Allergy Outlook report in partnership with GSK Consumer Healthcare’s Flonase Allergy Relief brand. The Allergy Outlook provides timely information on mold, pollen and air quality levels. Launching initially in British Columbia, where seasonal allergies typically begin in February, the Allergy Outlook is slated
WARREN, N.J. — GSK Consumer Healthcare has expanded its Flonase over-the-counter allergy relief nasal spray line with Flonase Sensimist, designed to offer a more comfortable spray experience. GSK said Wednesday Flonase Sensimist Allergy Relief (fluticasone furoate 27.5 mcg spray) features MistPro technology, which delivers a fine, gentle but powerful mist spray. Take once daily, the
WARREN, N.J. — GSK Consumer Healthcare has unveiled state-of-the-art Innovation Labs designed to help the company better meet consumer needs. The facilities, at the company’s new U.S. headquarters in Warren, N.J., cover a product’s life cycle, spanning research, development, testing, in-store placement and e-commerce. The labs interact to foster collaboration among scientists and the sales
LONDON — Brian McNamara has been promoted to chief executive officer of GlaxoSmithKline plc’s consumer health business. GSK said McNamara assumes the GSK Consumer Healthcare CEO post and joins GSK’s corporate executive team effective immediately. He takes the reins from Emma Walmsley, who just over a week ago was named to succeed Sir Andrew Witty
LONDON — Emma Walmsley has been named to succeed Sir Andrew Witty as chief executive officer of GlaxoSmithKline plc. The drug maker said Tuesday that Walmsley, CEO of GSK Consumer Healthcare, is slated to take the reins from Witty when he retires on March 31, 2017. Plans call for her to become a member of
WOONSOCKET, R.I. — CVS Health has launched an in-store fundraising campaign to benefit Stand Up To Cancer (SU2C), a program that supports cancer research to facilitate new therapies and help save more lives. CVS said Tuesday that through Oct. 1, customers can make a $1, $3 or larger donation to SU2C at checkout in CVS Pharmacy locations nationwide
WARREN, N.J. — GSK Consumer Healthcare has launched Children’s Flonase, a pediatric version of its now over-the-counter allergy nasal spray. GlaxoSmithKline said Tuesday that Children’s Flonase is approved to offer non-drowsy relief of allergy symptoms including runny nose, sneezing, itchy nose and congestion, as well as itchy, watery eyes. Available in stores nationwide in the